Market Analysis and Insights: Global IBS-C Drugs Market
The global IBS-C Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global IBS-C Drugs Scope and Segment
The global IBS-C Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IBS-C Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the IBS-C Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The IBS-C Drugs key manufacturers in this market include:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
The global IBS-C Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global IBS-C Drugs Scope and Segment
The global IBS-C Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IBS-C Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the IBS-C Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The IBS-C Drugs key manufacturers in this market include:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
1 IBS-C Drugs Market Overview
1.1 IBS-C Drugs Product Overview
1.2 IBS-C Drugs Market Segment by Type
1.2.1 Linaclotide
1.2.2 Lubiprostone
1.2.3 Osmotic Laxatives
1.2.4 Stimulant Laxatives
1.2.5 Others
1.3 Global IBS-C Drugs Market Size by Type
1.3.1 Global IBS-C Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global IBS-C Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global IBS-C Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global IBS-C Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global IBS-C Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global IBS-C Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global IBS-C Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global IBS-C Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global IBS-C Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa IBS-C Drugs Sales Breakdown by Type (2016-2021)
2 Global IBS-C Drugs Market Competition by Company
2.1 Global Top Players by IBS-C Drugs Sales (2016-2021)
2.2 Global Top Players by IBS-C Drugs Revenue (2016-2021)
2.3 Global Top Players IBS-C Drugs Price (2016-2021)
2.4 Global Top Manufacturers IBS-C Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 IBS-C Drugs Market Competitive Situation and Trends
2.5.1 IBS-C Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by IBS-C Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IBS-C Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into IBS-C Drugs Market
2.8 Key Manufacturers IBS-C Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 IBS-C Drugs Status and Outlook by Region
3.1 Global IBS-C Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global IBS-C Drugs Historic Market Size by Region
3.2.1 Global IBS-C Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global IBS-C Drugs Sales in Value by Region (2016-2021)
3.2.3 Global IBS-C Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global IBS-C Drugs Forecasted Market Size by Region
3.3.1 Global IBS-C Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global IBS-C Drugs Sales in Value by Region (2022-2027)
3.3.3 Global IBS-C Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global IBS-C Drugs by Application
4.1 IBS-C Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global IBS-C Drugs Market Size by Application
4.2.1 Global IBS-C Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global IBS-C Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global IBS-C Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global IBS-C Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global IBS-C Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global IBS-C Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global IBS-C Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global IBS-C Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global IBS-C Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa IBS-C Drugs Sales Breakdown by Application (2016-2021)
5 North America IBS-C Drugs by Country
5.1 North America IBS-C Drugs Historic Market Size by Country
5.1.1 North America IBS-C Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America IBS-C Drugs Sales in Value by Country (2016-2021)
5.2 North America IBS-C Drugs Forecasted Market Size by Country
5.2.1 North America IBS-C Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America IBS-C Drugs Sales in Value by Country (2022-2027)
6 Europe IBS-C Drugs by Country
6.1 Europe IBS-C Drugs Historic Market Size by Country
6.1.1 Europe IBS-C Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe IBS-C Drugs Sales in Value by Country (2016-2021)
6.2 Europe IBS-C Drugs Forecasted Market Size by Country
6.2.1 Europe IBS-C Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe IBS-C Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific IBS-C Drugs by Region
7.1 Asia-Pacific IBS-C Drugs Historic Market Size by Region
7.1.1 Asia-Pacific IBS-C Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific IBS-C Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific IBS-C Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific IBS-C Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific IBS-C Drugs Sales in Value by Region (2022-2027)
8 Latin America IBS-C Drugs by Country
8.1 Latin America IBS-C Drugs Historic Market Size by Country
8.1.1 Latin America IBS-C Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America IBS-C Drugs Sales in Value by Country (2016-2021)
8.2 Latin America IBS-C Drugs Forecasted Market Size by Country
8.2.1 Latin America IBS-C Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America IBS-C Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa IBS-C Drugs by Country
9.1 Middle East and Africa IBS-C Drugs Historic Market Size by Country
9.1.1 Middle East and Africa IBS-C Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa IBS-C Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa IBS-C Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa IBS-C Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa IBS-C Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in IBS-C Drugs Business
10.1 Catalent Pharmaceuticals Solutions
10.1.1 Catalent Pharmaceuticals Solutions Corporation Information
10.1.2 Catalent Pharmaceuticals Solutions Introduction and Business Overview
10.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Products Offered
10.1.5 Catalent Pharmaceuticals Solutions Recent Development
10.2 Nestle
10.2.1 Nestle Corporation Information
10.2.2 Nestle Introduction and Business Overview
10.2.3 Nestle IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Products Offered
10.2.5 Nestle Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Corporation Information
10.3.2 Abbott Laboratories Introduction and Business Overview
10.3.3 Abbott Laboratories IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Abbott Laboratories IBS-C Drugs Products Offered
10.3.5 Abbott Laboratories Recent Development
10.4 Synergy Pharmaceuticals
10.4.1 Synergy Pharmaceuticals Corporation Information
10.4.2 Synergy Pharmaceuticals Introduction and Business Overview
10.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Synergy Pharmaceuticals IBS-C Drugs Products Offered
10.4.5 Synergy Pharmaceuticals Recent Development
10.5 Sucampo Pharmaceuticals
10.5.1 Sucampo Pharmaceuticals Corporation Information
10.5.2 Sucampo Pharmaceuticals Introduction and Business Overview
10.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Sucampo Pharmaceuticals IBS-C Drugs Products Offered
10.5.5 Sucampo Pharmaceuticals Recent Development
10.6 Novartis Pharma Ag
10.6.1 Novartis Pharma Ag Corporation Information
10.6.2 Novartis Pharma Ag Introduction and Business Overview
10.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Novartis Pharma Ag IBS-C Drugs Products Offered
10.6.5 Novartis Pharma Ag Recent Development
10.7 Astellas Pharmaceuticals
10.7.1 Astellas Pharmaceuticals Corporation Information
10.7.2 Astellas Pharmaceuticals Introduction and Business Overview
10.7.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Astellas Pharmaceuticals IBS-C Drugs Products Offered
10.7.5 Astellas Pharmaceuticals Recent Development
10.8 Ardelyx, Inc
10.8.1 Ardelyx, Inc Corporation Information
10.8.2 Ardelyx, Inc Introduction and Business Overview
10.8.3 Ardelyx, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Ardelyx, Inc IBS-C Drugs Products Offered
10.8.5 Ardelyx, Inc Recent Development
10.9 Synthetic Biologics, Inc
10.9.1 Synthetic Biologics, Inc Corporation Information
10.9.2 Synthetic Biologics, Inc Introduction and Business Overview
10.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Synthetic Biologics, Inc IBS-C Drugs Products Offered
10.9.5 Synthetic Biologics, Inc Recent Development
10.10 Teva Pharmaceutical Industries
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 IBS-C Drugs Product Category, Application and Specification
10.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Teva Pharmaceutical Industries Recent Development
10.11 Bama-Geve, SLU
10.11.1 Bama-Geve, SLU Corporation Information
10.11.2 Bama-Geve, SLU Introduction and Business Overview
10.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Bama-Geve, SLU IBS-C Drugs Products Offered
10.11.5 Bama-Geve, SLU Recent Development
10.12 Ferring BV
10.12.1 Ferring BV Corporation Information
10.12.2 Ferring BV Introduction and Business Overview
10.12.3 Ferring BV IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Ferring BV IBS-C Drugs Products Offered
10.12.5 Ferring BV Recent Development
10.13 Ironwood Pharmaceuticals, Inc
10.13.1 Ironwood Pharmaceuticals, Inc Corporation Information
10.13.2 Ironwood Pharmaceuticals, Inc Introduction and Business Overview
10.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Products Offered
10.13.5 Ironwood Pharmaceuticals, Inc Recent Development
10.14 Salix Pharmaceuticals Ltd
10.14.1 Salix Pharmaceuticals Ltd Corporation Information
10.14.2 Salix Pharmaceuticals Ltd Introduction and Business Overview
10.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Products Offered
10.14.5 Salix Pharmaceuticals Ltd Recent Development
10.15 Norgine B.V
10.15.1 Norgine B.V Corporation Information
10.15.2 Norgine B.V Introduction and Business Overview
10.15.3 Norgine B.V IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Norgine B.V IBS-C Drugs Products Offered
10.15.5 Norgine B.V Recent Development
10.16 Prometheus Laboratories Inc
10.16.1 Prometheus Laboratories Inc Corporation Information
10.16.2 Prometheus Laboratories Inc Introduction and Business Overview
10.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Prometheus Laboratories Inc IBS-C Drugs Products Offered
10.16.5 Prometheus Laboratories Inc Recent Development
10.17 Actavis Nordic A/S
10.17.1 Actavis Nordic A/S Corporation Information
10.17.2 Actavis Nordic A/S Introduction and Business Overview
10.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Actavis Nordic A/S IBS-C Drugs Products Offered
10.17.5 Actavis Nordic A/S Recent Development
10.18 Albireo Pharma Inc
10.18.1 Albireo Pharma Inc Corporation Information
10.18.2 Albireo Pharma Inc Introduction and Business Overview
10.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Albireo Pharma Inc IBS-C Drugs Products Offered
10.18.5 Albireo Pharma Inc Recent Development
10.19 Yuhan Corp
10.19.1 Yuhan Corp Corporation Information
10.19.2 Yuhan Corp Introduction and Business Overview
10.19.3 Yuhan Corp IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Yuhan Corp IBS-C Drugs Products Offered
10.19.5 Yuhan Corp Recent Development
10.20 Astrazeneca Plc
10.20.1 Astrazeneca Plc Corporation Information
10.20.2 Astrazeneca Plc Introduction and Business Overview
10.20.3 Astrazeneca Plc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Astrazeneca Plc IBS-C Drugs Products Offered
10.20.5 Astrazeneca Plc Recent Development
10.21 The Menarini Group
10.21.1 The Menarini Group Corporation Information
10.21.2 The Menarini Group Introduction and Business Overview
10.21.3 The Menarini Group IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.21.4 The Menarini Group IBS-C Drugs Products Offered
10.21.5 The Menarini Group Recent Development
10.22 Ono Pharmaceutical Co., Ltd
10.22.1 Ono Pharmaceutical Co., Ltd Corporation Information
10.22.2 Ono Pharmaceutical Co., Ltd Introduction and Business Overview
10.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Products Offered
10.22.5 Ono Pharmaceutical Co., Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 IBS-C Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 IBS-C Drugs Industrial Chain Analysis
11.4 IBS-C Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 IBS-C Drugs Distributors
12.3 IBS-C Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 IBS-C Drugs Product Overview
1.2 IBS-C Drugs Market Segment by Type
1.2.1 Linaclotide
1.2.2 Lubiprostone
1.2.3 Osmotic Laxatives
1.2.4 Stimulant Laxatives
1.2.5 Others
1.3 Global IBS-C Drugs Market Size by Type
1.3.1 Global IBS-C Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global IBS-C Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global IBS-C Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global IBS-C Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global IBS-C Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global IBS-C Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global IBS-C Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global IBS-C Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global IBS-C Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America IBS-C Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa IBS-C Drugs Sales Breakdown by Type (2016-2021)
2 Global IBS-C Drugs Market Competition by Company
2.1 Global Top Players by IBS-C Drugs Sales (2016-2021)
2.2 Global Top Players by IBS-C Drugs Revenue (2016-2021)
2.3 Global Top Players IBS-C Drugs Price (2016-2021)
2.4 Global Top Manufacturers IBS-C Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 IBS-C Drugs Market Competitive Situation and Trends
2.5.1 IBS-C Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by IBS-C Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IBS-C Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into IBS-C Drugs Market
2.8 Key Manufacturers IBS-C Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 IBS-C Drugs Status and Outlook by Region
3.1 Global IBS-C Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global IBS-C Drugs Historic Market Size by Region
3.2.1 Global IBS-C Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global IBS-C Drugs Sales in Value by Region (2016-2021)
3.2.3 Global IBS-C Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global IBS-C Drugs Forecasted Market Size by Region
3.3.1 Global IBS-C Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global IBS-C Drugs Sales in Value by Region (2022-2027)
3.3.3 Global IBS-C Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global IBS-C Drugs by Application
4.1 IBS-C Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global IBS-C Drugs Market Size by Application
4.2.1 Global IBS-C Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global IBS-C Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global IBS-C Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global IBS-C Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global IBS-C Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global IBS-C Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global IBS-C Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global IBS-C Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global IBS-C Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America IBS-C Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa IBS-C Drugs Sales Breakdown by Application (2016-2021)
5 North America IBS-C Drugs by Country
5.1 North America IBS-C Drugs Historic Market Size by Country
5.1.1 North America IBS-C Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America IBS-C Drugs Sales in Value by Country (2016-2021)
5.2 North America IBS-C Drugs Forecasted Market Size by Country
5.2.1 North America IBS-C Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America IBS-C Drugs Sales in Value by Country (2022-2027)
6 Europe IBS-C Drugs by Country
6.1 Europe IBS-C Drugs Historic Market Size by Country
6.1.1 Europe IBS-C Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe IBS-C Drugs Sales in Value by Country (2016-2021)
6.2 Europe IBS-C Drugs Forecasted Market Size by Country
6.2.1 Europe IBS-C Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe IBS-C Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific IBS-C Drugs by Region
7.1 Asia-Pacific IBS-C Drugs Historic Market Size by Region
7.1.1 Asia-Pacific IBS-C Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific IBS-C Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific IBS-C Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific IBS-C Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific IBS-C Drugs Sales in Value by Region (2022-2027)
8 Latin America IBS-C Drugs by Country
8.1 Latin America IBS-C Drugs Historic Market Size by Country
8.1.1 Latin America IBS-C Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America IBS-C Drugs Sales in Value by Country (2016-2021)
8.2 Latin America IBS-C Drugs Forecasted Market Size by Country
8.2.1 Latin America IBS-C Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America IBS-C Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa IBS-C Drugs by Country
9.1 Middle East and Africa IBS-C Drugs Historic Market Size by Country
9.1.1 Middle East and Africa IBS-C Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa IBS-C Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa IBS-C Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa IBS-C Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa IBS-C Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in IBS-C Drugs Business
10.1 Catalent Pharmaceuticals Solutions
10.1.1 Catalent Pharmaceuticals Solutions Corporation Information
10.1.2 Catalent Pharmaceuticals Solutions Introduction and Business Overview
10.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Products Offered
10.1.5 Catalent Pharmaceuticals Solutions Recent Development
10.2 Nestle
10.2.1 Nestle Corporation Information
10.2.2 Nestle Introduction and Business Overview
10.2.3 Nestle IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Products Offered
10.2.5 Nestle Recent Development
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Corporation Information
10.3.2 Abbott Laboratories Introduction and Business Overview
10.3.3 Abbott Laboratories IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Abbott Laboratories IBS-C Drugs Products Offered
10.3.5 Abbott Laboratories Recent Development
10.4 Synergy Pharmaceuticals
10.4.1 Synergy Pharmaceuticals Corporation Information
10.4.2 Synergy Pharmaceuticals Introduction and Business Overview
10.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Synergy Pharmaceuticals IBS-C Drugs Products Offered
10.4.5 Synergy Pharmaceuticals Recent Development
10.5 Sucampo Pharmaceuticals
10.5.1 Sucampo Pharmaceuticals Corporation Information
10.5.2 Sucampo Pharmaceuticals Introduction and Business Overview
10.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Sucampo Pharmaceuticals IBS-C Drugs Products Offered
10.5.5 Sucampo Pharmaceuticals Recent Development
10.6 Novartis Pharma Ag
10.6.1 Novartis Pharma Ag Corporation Information
10.6.2 Novartis Pharma Ag Introduction and Business Overview
10.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Novartis Pharma Ag IBS-C Drugs Products Offered
10.6.5 Novartis Pharma Ag Recent Development
10.7 Astellas Pharmaceuticals
10.7.1 Astellas Pharmaceuticals Corporation Information
10.7.2 Astellas Pharmaceuticals Introduction and Business Overview
10.7.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Astellas Pharmaceuticals IBS-C Drugs Products Offered
10.7.5 Astellas Pharmaceuticals Recent Development
10.8 Ardelyx, Inc
10.8.1 Ardelyx, Inc Corporation Information
10.8.2 Ardelyx, Inc Introduction and Business Overview
10.8.3 Ardelyx, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Ardelyx, Inc IBS-C Drugs Products Offered
10.8.5 Ardelyx, Inc Recent Development
10.9 Synthetic Biologics, Inc
10.9.1 Synthetic Biologics, Inc Corporation Information
10.9.2 Synthetic Biologics, Inc Introduction and Business Overview
10.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Synthetic Biologics, Inc IBS-C Drugs Products Offered
10.9.5 Synthetic Biologics, Inc Recent Development
10.10 Teva Pharmaceutical Industries
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 IBS-C Drugs Product Category, Application and Specification
10.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Teva Pharmaceutical Industries Recent Development
10.11 Bama-Geve, SLU
10.11.1 Bama-Geve, SLU Corporation Information
10.11.2 Bama-Geve, SLU Introduction and Business Overview
10.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Bama-Geve, SLU IBS-C Drugs Products Offered
10.11.5 Bama-Geve, SLU Recent Development
10.12 Ferring BV
10.12.1 Ferring BV Corporation Information
10.12.2 Ferring BV Introduction and Business Overview
10.12.3 Ferring BV IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Ferring BV IBS-C Drugs Products Offered
10.12.5 Ferring BV Recent Development
10.13 Ironwood Pharmaceuticals, Inc
10.13.1 Ironwood Pharmaceuticals, Inc Corporation Information
10.13.2 Ironwood Pharmaceuticals, Inc Introduction and Business Overview
10.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Products Offered
10.13.5 Ironwood Pharmaceuticals, Inc Recent Development
10.14 Salix Pharmaceuticals Ltd
10.14.1 Salix Pharmaceuticals Ltd Corporation Information
10.14.2 Salix Pharmaceuticals Ltd Introduction and Business Overview
10.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Products Offered
10.14.5 Salix Pharmaceuticals Ltd Recent Development
10.15 Norgine B.V
10.15.1 Norgine B.V Corporation Information
10.15.2 Norgine B.V Introduction and Business Overview
10.15.3 Norgine B.V IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Norgine B.V IBS-C Drugs Products Offered
10.15.5 Norgine B.V Recent Development
10.16 Prometheus Laboratories Inc
10.16.1 Prometheus Laboratories Inc Corporation Information
10.16.2 Prometheus Laboratories Inc Introduction and Business Overview
10.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Prometheus Laboratories Inc IBS-C Drugs Products Offered
10.16.5 Prometheus Laboratories Inc Recent Development
10.17 Actavis Nordic A/S
10.17.1 Actavis Nordic A/S Corporation Information
10.17.2 Actavis Nordic A/S Introduction and Business Overview
10.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Actavis Nordic A/S IBS-C Drugs Products Offered
10.17.5 Actavis Nordic A/S Recent Development
10.18 Albireo Pharma Inc
10.18.1 Albireo Pharma Inc Corporation Information
10.18.2 Albireo Pharma Inc Introduction and Business Overview
10.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Albireo Pharma Inc IBS-C Drugs Products Offered
10.18.5 Albireo Pharma Inc Recent Development
10.19 Yuhan Corp
10.19.1 Yuhan Corp Corporation Information
10.19.2 Yuhan Corp Introduction and Business Overview
10.19.3 Yuhan Corp IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Yuhan Corp IBS-C Drugs Products Offered
10.19.5 Yuhan Corp Recent Development
10.20 Astrazeneca Plc
10.20.1 Astrazeneca Plc Corporation Information
10.20.2 Astrazeneca Plc Introduction and Business Overview
10.20.3 Astrazeneca Plc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Astrazeneca Plc IBS-C Drugs Products Offered
10.20.5 Astrazeneca Plc Recent Development
10.21 The Menarini Group
10.21.1 The Menarini Group Corporation Information
10.21.2 The Menarini Group Introduction and Business Overview
10.21.3 The Menarini Group IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.21.4 The Menarini Group IBS-C Drugs Products Offered
10.21.5 The Menarini Group Recent Development
10.22 Ono Pharmaceutical Co., Ltd
10.22.1 Ono Pharmaceutical Co., Ltd Corporation Information
10.22.2 Ono Pharmaceutical Co., Ltd Introduction and Business Overview
10.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021)
10.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Products Offered
10.22.5 Ono Pharmaceutical Co., Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 IBS-C Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 IBS-C Drugs Industrial Chain Analysis
11.4 IBS-C Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 IBS-C Drugs Distributors
12.3 IBS-C Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
